Crossref
Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026d49p64ee ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Yi-Lun Zhou und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhou, Y., & Alemasi, A. (2026). Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026d49p64ee
Vancouver
Zhou Y, Alemasi A. Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026d49p64ee
BibTeX
@article{Zhou2026,
author = {Zhou, Yi-Lun and Alemasi, Akehu},
title = {Ticagrelor vs. Clopidogrel Treatment in Chinese Patients with CKD After Percutaneous Coronary Intervention: Implications for East Asia},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026d49p64ee}
}
EUVIMED